Genentech Age-related Macular Degeneration Research Fellowships
In the U.S. alone, 1.8 million Americans have Age-related Macular Degeneration (AMD), and this number is expected to reach 2.9 million by 2020 according to a study released in 2012 by Prevent Blindness America and the National Eye Institute. Eye and vision researchers have already discovered several genes at work in AMD, the distinctions between types of AMD and the development of therapeutic remedies. The ARVO Foundation for Eye Research believes the work must continue so that there can be earlier identification of those likely to develop AMD, discovery of ways to slow the progression of the disease and novel ways to treat AMD to limit sight loss. Thanks to Genentech's support, the ARVO Foundation will offer one grant to a researcher working in basic research in the understanding of AMD and another grant to a researcher working in translational AMD research focusing on therapeutics.
View the 2013 Genentech Age-related Macular Degeneration Research Fellowships recipients.
The Genentech Age-related Macular Degeneration (AMD) Research Fellowships were created in 2011, they are made available through the support of Genentech. View previous recipients.
2014 Genentech AMD Fellowships timeline
||June 16, 2014
||Sept. 30, 2014